2m 2m 2m 2m 2m 2m 2m
ALTIMMUNE (ALT)
NASDAQ
$2.94+$0.005 (+0.17%)
Price as of Jun 23, 2026 5:43 PM EDT- $569.8MMarket Cap
- -58.08%1-Year Change
- BiotechnologyIndustry
ALTIMMUNE (ALT)
$2.94+$0.005 (+0.17%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 41,000 +105.00% | 20,000 -95.31% | 426,000 +726.47% | -68,000 -101.54% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 41,000 +105.00% | 20,000 -95.31% | 426,000 +726.47% | -68,000 -101.54% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -66.4M -19.21% | -82.2M +24.97% | -65.8M -6.72% | -70.5M -5.37% | |
Depreciation and Amortization Expense | 112,000 -52.94% | 238,000 -50.10% | 477,000 +332.68% | -205,000 -137.18% | |
Total Operating Expenses | 94.5M -8.39% | 103.2M +7.10% | 96.4M +9.90% | 87.7M -13.47% | |
Operating Profit | -94.5M -8.42% | -103.2M +7.55% | -95.9M +9.33% | -87.7M -9.47% | |
Interest Income | 7.5M -6.60% | 8.1M +9.84% | 7.4M +156.13% | 2.9M +1,315.60% | |
Interest Expense | -1.6M N/A | N/A N/A | -35,000 +337.50% | -8,000 +41.44% | |
Interest Income and Expense and Net | 5.9M -26.42% | 8.1M +10.36% | 7.3M +155.63% | 2.9M +1,352.17% | |
Total Nonoperating Income and Expense | 5.7M -29.56% | 8.1M +8.43% | 7.5M +164.38% | 2.8M +1,700.83% | |
Income before Taxes | -88.8M -13.96% | -103.2M +16.65% | -88.4M +4.17% | -84.9M -12.55% | |
Income Taxes | -681,000 N/A | N/A N/A | -197,000 0.00% | -197,000 -96.36% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -88.1M -7.33% | -95.1M +7.48% | -88.4M +4.41% | -84.7M -12.75% | |
Net Income from Continuing Operations Applicable to Common | -88.8M -6.61% | -95.1M +7.48% | -88.4M +4.17% | -84.9M -12.55% | |
Basic EPS and Net Income | -1.00 -25.37% | -1.34 -19.28% | -1.66 -8.29% | -1.81 -22.98% | |
Diluted EPS and Net Income | -1.00 -25.37% | -1.34 -19.28% | -1.66 -8.29% | -1.81 -22.98% | |
Basic Weighted Average Shares | 88.1M +24.08% | 71.0M +33.35% | 53.2M +13.47% | 46.9M +13.67% | |
Diluted Weighted Average Shares | 88.1M +24.08% | 71.0M +33.35% | 53.2M +13.47% | 46.9M +13.67% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 43.8M +18.51% | 36.9M -72.67% | 135.1M +21.62% | 111.1M -41.62% | |
Short-Term Investments | 229.7M +141.87% | 95.0M +51.46% | 62.7M -15.02% | 73.8M -26.22% | |
Cash and Cash Equivalents and Short-Term Investments | 273.5M +107.33% | 131.9M -33.33% | 197.8M +7.00% | 184.9M -36.32% | |
Total Current Assets | 278.2M +102.68% | 137.3M -34.52% | 209.6M +8.72% | 192.8M -5.54% | |
Accumulated Depreciation | 2.3M +5.06% | 2.2M +12.05% | 2.0M +31.84% | 1.5M -26.82% | |
Property and Plant and Equipment and Net | 312,000 -24.46% | 413,000 -36.56% | 651,000 -39.78% | 1.1M -25.33% | |
Total Long-Term Assets | 1.4M -13.06% | 1.6M +351.52% | 363,000 -40.98% | 615,000 -29.47% | |
Total Assets | 279.9M +100.95% | 139.3M -33.87% | 210.6M +1.79% | 206.9M -5.45% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 15.0M +43.27% | 10.5M -13.79% | 12.1M -28.80% | 17.1M -6.69% | |
Total Long-Term Debt | 34.3M N/A | N/A N/A | N/A N/A | 4.6M +215.02% | |
Total Long-Term Liabilities | 5.8M +7.94% | 5.3M +21.19% | 4.4M +7,230.00% | 60,000 -25.50% | |
Total Liabilities | 55.0M +248.38% | 15.8M -4.49% | 16.5M -23.55% | 21.6M +9.65% | |
Retained Earnings | -649.5M +15.69% | -561.4M +20.38% | -466.3M +23.41% | -377.9M +28.90% | |
Total Stockholders Equity | 224.9M +82.09% | 123.5M -36.37% | 194.1M +4.75% | 185.3M -6.95% | |
Total Shares Outstanding | 110.9M +53.25% | 72.4M +2.37% | 70.7M +43.65% | 49.2M +20.02% | |
Cash Flow | |||||
Cash from Operating Activities | -67.5M -15.42% | -79.8M +5.33% | -75.8M +21.13% | -62.6M -20.01% | |
Capital Expenditures | 11,000 -76.60% | 47,000 0.00% | 47,000 -62.70% | 126,000 -98.96% | |
Cash from Investing Activities | -132.5M +366.68% | -28.4M -306.71% | 13.7M +118.71% | -73.4M -183.86% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 206.8M +1,959.36% | 10.0M -88.34% | 86.1M +51.64% | 56.8M -12.78% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -230,460.98% -55.32% | -515,860.00% +2,190.82% | -22,518.54% -117.45% | 129,029.41% +5,971.86% | |
Return on Assets | -42.03% -22.64% | -54.33% +28.24% | -42.36% +6.46% | -39.79% -4.92% | |
Return on Equity | -50.57% -15.52% | -59.86% +28.38% | -46.63% +5.79% | -44.07% -3.54% | |
Revenue Growth | 105.00% +210.17% | -95.31% -113.12% | 726.47% +815.44% | -101.54% +120.18% | |
Current Ratio | 18.55 +41.47% | 13.11 -24.05% | 17.26 +52.69% | 11.31 +1.23% | |
Cash Ratio | 2.92 -17.28% | 3.53 -68.30% | 11.13 +70.81% | 6.51 -37.44% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow